- Previous Close
0.0000 - Open
0.0001 - Bid --
- Ask --
- Day's Range
0.0001 - 0.0001 - 52 Week Range
0.0001 - 0.1180 - Volume
240 - Avg. Volume
50 - Market Cap (intraday)
108,254 - Beta (5Y Monthly) 0.62
- PE Ratio (TTM)
∞ - EPS (TTM)
0.0000 - Earnings Date Mar 10, 2025
- Forward Dividend & Yield 0.00 (2.18%)
- Ex-Dividend Date May 23, 2025
- 1y Target Est
--
Tian An Medicare Limited, an investment holding company, primarily operates hospitals in the People's Republic of China and Hong Kong. It operates through six segments: Healthcare, Eldercare, Property Development, Property Investment, Financial Services, and Securities Trading and Investments. The company also involved in property development of independent living units and project management of health campus with a focus on eldercare and retirement community including elderly nursing home, service apartments, independent living units and commercial area comprising shopping mall, retail shops, and club hall facilities. In addition, it develops and sells properties and lands; leases residential and office properties; and provides loan financial and healthcare services, as well as trading of securities listed in overseas exchange. The company was formerly known as China Medical & HealthCare Group Limited and changed its name to Tian An Medicare Limited in April 2024. The company was incorporated in 1989 and is headquartered in Wan Chai, Hong Kong. Tian An Medicare Limited is a subsidiary of Tian An China Investments Company Limited.
www.tiananmedicare.com.hk2,626
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: COLRF
View MorePerformance Overview: COLRF
Trailing total returns as of 4/7/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: COLRF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: COLRF
View MoreValuation Measures
Market Cap
108.56M
Enterprise Value
101.59M
Trailing P/E
34.66
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.61
Price/Book (mrq)
0.55
Enterprise Value/Revenue
0.49
Enterprise Value/EBITDA
9.18
Financial Highlights
Profitability and Income Statement
Profit Margin
1.77%
Return on Assets (ttm)
1.71%
Return on Equity (ttm)
2.21%
Revenue (ttm)
1.63B
Net Income Avi to Common (ttm)
28.77M
Diluted EPS (ttm)
0.0000
Balance Sheet and Cash Flow
Total Cash (mrq)
885.43M
Total Debt/Equity (mrq)
44.13%
Levered Free Cash Flow (ttm)
--